Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Nature Cancer|May 15, 2024
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profilingAli Rezvan, Gabrielle Romain, Mohsen Fathi, et al.
Neuro-Oncology|March 11, 2020
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymomaSoumen Khatua, Laurence J N Cooper, David I Sandberg, et al.
Frontiers in Immunology|November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignanciesHarjeet Singh, Samer A Srour, Denái R Milton, et al.
Science Translational Medicine|August 16, 2019
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trialE Antonio Chiocca, John S Yu, Rimas V Lukas, et al.
Blood|April 28, 2016
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHLXiuli Wang, Leslie L Popplewell, Jamie R Wagner, et al.
The New England Journal of Medicine|December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell cocultureMarcos de Lima, Ian McNiece, Simon N Robinson, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicitySimone Punt, Shruti Malu, Jodi A McKenzie, et al.
Blood|March 18, 2015
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantationUday Popat, Rohtesh S Mehta, Katayoun Rezvani, et al.
The Journal of Clinical Investigation|August 3, 2016
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cellsPartow Kebriaei, Harjeet Singh, M Helen Huls, et al.
Nature Communications|April 5, 2016
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancerSherry Y Wu, Rajesha Rupaimoole, Fangrong Shen, et al.
Pageof 14